Advertisement
Most patients with thrombocytopenia have circulating histones

SCCM: Circulating Histones for Most With Thrombocytopenia

0
Circulating histones for 91 percent of patients with thrombocytopenia, 55 percent of controls
Exercise does not appear to result in significant improvements in physical functioning in women living with advanced breast cancer

Exercise No Aid to Functioning With Advanced Breast Cancer

0
Intervention didn't increase weekly exercise or physical functioning
Some women aged 40 to 49 years with estrogen receptor-positive breast cancer who undergo chemotherapy-induced amenorrhea regain ovarian function with letrozole

Letrozole Tied to Ovarian Function Recovery in Chemo

0
Findings in women aged 40 to 49 years with estrogen receptor-positive breast cancer
Geriatric events are common among elderly patients who undergo major surgery for cancer

Geriatric Events in Cancer Surgery Common in Elderly

0
Particularly among those who undergo major abdominal surgery
The 90-day rate of reoperation following breast conservation surgery for early-stage breast cancer has decreased overall and varies widely by surgeon

Breast CA Surgery Reoperation Rates Vary by Surgeon

0
90-day reoperation rate for breast conserving surgery dropped from 40 to nearly 25 percent
Higher levels of ferritin and transferrin correlate with increased risk of type 2 diabetes among men and women

Ferritin, Transferrin Positively Linked to Type 2 Diabetes

0
Higher levels tied to higher risk of T2D in men and women; TSAT linked to risk in women
Women with hyperthyroidism have increased breast cancer risk

Thyroid Function Level Linked to Breast Cancer Risk

0
Increased risk of breast cancer in women with hyperthyroidism; lower risk for hypothyroidism
Most medical schools need to post

Many Med Schools Appear Unwelcoming Regarding Disability

0
Only one-third of medical schools have technical standards supporting accommodating disabilities
Vitamin E supplementation can reduce cisplatin-induced ototoxicity

Vitamin E Neuroprotective Against Cisplatin Ototoxicity

0
Placebo group had significant hearing loss at one month at both 2,000 HZ and 8,000 HZ
Erythropoietin-stimulating agents do not improve health-related quality of life in patients with anemia of chronic kidney disease

ESAs Don’t Improve Quality of Life in Anemia of CKD

0
Based on effect of erythropoietin-stimulating agents for higher hemoglobin targets